Journals / Klinik Tıp Bilimleri / 2017 / Cilt: 5 - Sayı: 4

Diagnosis and Treatment of Gastrointestinal System Autonomic Neuropathy

Gastrointestinal Sistem Otonom Nöropatinin Tanı ve Tedavisi

Pages
60–62
Publication Date
2017-04-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Questioningthe symptoms of GIS autonomic neuropathy symptoms in diabetic patient sand puttin geffort for the treatment will help this important morbidity toresolv eandim provequalityof life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractGastrointestinal autonomic neuropathy is one of the most common clinical problemsin diabetic patients.
📊
Key Findings & Data:It represents as delayed gastric emptying (gastroparesis), dysphagia, earlysatiety, nausea, vomiting (decreased motility), delayed food absorption, constipation (atonic colon), night diarrhoea, cholecystitis and biliary sludge (atonic gall bladder).
💡
Conclusion & Impact:Questioningthe symptoms of GIS autonomic neuropathy symptoms in diabetic patient sand puttin geffort for the treatment will help this important morbidity toresolv eandim provequalityof life.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diyabetes mellitus · otonom nöropati · astrointestinal sistem

Abstract

AbstractGastrointestinal autonomic neuropathy is one of the most common clinical problemsin diabetic patients. It might cause fluctutations in blood glucosel evels and a decresa-se inquality of life. It represents as delayed gastric emptying (gastroparesis), dysphagia, earlysatiety, nausea, vomiting (decreased motility), delayed food absorption, constipation (atonic colon), night diarrhoea, cholecystitis and biliary sludge (atonic gall bladder). Diagnosis is made by scintigraphic evaluation of GIS motility, radio-opaquemarkers, gastric emptying breath testing and wireless motilitycapsule. Treatment methods are; diabetes regulation, dietary changes (avoiding excess fat and fiber, more frequent eating inlesseramounts), medications (Gastroparesis: metoclopramide, domperidone, eritromisin Constipation: Laxatives, Prucalopride, Linaclotide, Pyridostigmine Diarrhoea: Loperamide, antibiotherapy Abdominalpain: Antidepressants) and GI stimulation. Questioningthe symptoms of GIS autonomic neuropathy symptoms in diabetic patient sand puttin geffort for the treatment will help this important morbidity toresolv eandim provequalityof life.

Özet

ÖzGastrointestinal otonom nöropati diyabetik hastalarda kliniğe en fazla yansıyan sorunlardan biridir. Kan şekerinde dalgalanmalara ve yaşam kalitesinde azalmaya nedenolabilir. Kendini mide boşalmasında gecikme (gastroparezi), yutma güçlüğü, çabuk doyma, bulantı, kusma (motilite azalması), alınan gıdaların emiliminin gecikmesi konstipasyon (kolon atonisi), gece diyareleri, kolesistit ve safra çamuru (safra kesesi atonisi) şeklinde gösterebilir. Tanı yöntemleri; klinik şüphe sonrası Gİ motilitenin sintigrafik değerlendirmesi, radyo-opak belirteçler, gastrik boşalma nefes testi ve “wireless” motilite kapsülünün kullanımını içerir.Tedavide kan şekeri regülasyonu, diyet tedavisi (az ve sık beslenme, fazla yağ ve lif içeriğinden kaçınmak), ilaç tedavisi (Gastroparezi: metoklopramid, domperidon, eritromisin; Konstipasyon: Laksatifler, Prucalopride, Linaclotide, Pyridostigmine; Diyare: Loperamide, antibiyoterapi; Karın ağrısı: Antidepresanlar); ve GIstimülasyonkullanılır. Diyabetik hastalarda önemli bir morbidite nedeni olan GIS otonom nöropatisemptomlarınınciddiye alınarak sorgulanması ve tedavi için çaba harcanması, diyabetik hastaların yaşam kalitesini önemli derecede arttıracaktır.

🔖

Cite This Article

AKBAŞ, D. D. F. (2017). Diagnosis and Treatment of Gastrointestinal System Autonomic Neuropathy. Klinik Tıp Bilimleri, Cilt: 5 - Sayı: 4, 60–62. https://ajindex.com/articles/838268

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kaynaklar 1.Harrison's Principles of InternalMedicine, 19th Edition TextbookPart16 EndocrinologyandMetabolism. Page 2426. 2015 byMcGraw-HillE-ducation.US 2.Gatopoulou A, Papanas N, Maltezos E. Diabetic gastrointestinal autono-mic neuropathy: current status and new achievements for everyday clini-cal practice.Eur J Intern Med. 2012 Sep
  2. 23(6):499-505. 3.Otonom Nöropati. DM Çalışma ve Eğitim Grubu. TEMD Diabetes Mellitusve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu 2016. Sayfa:146 4.Türkiye Diyabet Programı 2015-2020. TC Sağlık Bakanlığı Türkiye HalkSağlığı Kurumu. (cited March 2017) Avaliable at:http://diyabet.gov.tr/in-dex.php?lang=tr&page=94&newsCat=1&newsID=48 5.Kempler P, Várkonyi T, Körei AE, Horváth VJ. Gastrointestinal auto-nomic neuropathy in diabetes: the unattended borderline between dia-betology and gastroenterology.Diabetologia. 2016 Mar
  3. 59(3):401-3. 6.Feldman M, Schiller LR. Disorders of gastrointestinalmotilityassocia-tedwithdiabetesmellitus. AnnInternMed 1983
  4. Parkman HP, Hasler WL, Fisher RS, AmericanGastroenterologicalAsso-ciation. AmericanGastroenterologicalAssociationtechnicalreview on the-diagnosisandtreatment of gastroparesis. Gastroenterology 2004
  5. Choung RS, Locke GR 3rd, Schleck CD, et al. Risk of gastroparesis insubjectswithtype 1 and 2 diabetes in the general population. Am J Gas-troenterol 2012
  6. Janatuinen E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinalsymp-toms in middle-ageddiabeticpatients. Scand J Gastroenterol 1993
  7. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper-gastrointestinal motor andsensoryfunctionwithglycemiccontrol. Diabe-tesCare 2001
  8. Inadomi JM, Jamal R, Murata GH, et al. Step-downmanagement of gas-troesophagealrefluxdisease. Gastroenterology 2001
  9. DeVault KR, Castell DO, AmericanCollege of Gastroenterology. Upda-ted guidelines for the diagnosis and treatment of gastroesophageal refluxdi-sease. Am J Gastroenterol 2005
  10. Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. LifestyleIntervention in Gastroesophageal Reflux Disease. ClinGastroenterolHepatol 2016
  11. Guerci B, Bourgeois C, Bresler L, Scherrer ML, Böhme P. Gastric elect-rical stimulation for the treatment of diabetic gastroparesis. Diabetes Me-tab. 2012 Nov
  12. 38(5):393-402. 15. Rayner CK, Horowitz M. Gastrointestinal motilityandglycemiccontrolin diabetes: thechickenandtheeggrevisited? J ClinInvest 2006
  13. Rayner CK, Samsom M, Jone